GBP5 and tuberculosis: The observed factorial changes in the expression of these complement genes between TB patients and LTBI individuals were comparable with the changes as seen for FCGR1A and GBP5, which were previously described as promising and highly consistent biomarkers of active TB (Figure 1C).